Clinical Trial: AI-Driven Precision Cardiopulmonary-Cerebral Resuscitation Diagnostic and Therapeutic Strategy: Construction and Evaluation of Neuroprotective Effects (China)

Posted On: 2026-09-02

China, Sept. 2 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'AI-Driven Precision Cardiopulmonary-Cerebral Resuscitation Diagnostic and Therapeutic Strategy: Construction and Evaluation of Neuroprotective Effects'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131305

Registration Time: 2026/09/01

Type: Observational study

Primary Sponsor: Peking University Third Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=339129

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: AI-Driven Precision Cardiopulmonary-Cerebral Resuscitation Diagnostic and Therapeutic Strategy: Construction and Evaluation of Neuroprotective Effects (China)